ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab

Stefanini, B., Fulgenzi, C., Scheiner, B., Korolewicz, J., Cheon, J., Nishida, N., Ang, C., Marron, T., Wu, Y. L., Saeed, A., Wietharn, B., Rimassa, L., Pirozzi, A., Cammarota, A., Pressiani, T., Pinter, M., Balcar, L., Huang, Y.-H., Mehan, A., … D’Alessio, A. (2025). ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab. Journal of Hepatocellular Carcinoma, Volume 12, 671–683. https://doi.org/10.2147/jhc.s462701
Authors:
Bernardo Stefanini
Claudia Angela Maria Fulgenzi
Bernhard Scheiner
James Korolewicz
Aman Mehan
Giulia Francesca Manfredi
Ciro Celsa
Nichola Awosika
Alessio Cortellini
Rohini Sharma
David James Pinato
Antonio D'Alessio
Francesco Tovoli
Fabio Piscaglia
Matthias Pinter
Lorenz Balcar
Jaekyung Cheon
Hong Jae Chon
Naoshi Nishida
Masatoshi Kudo
Celina Ang
Thomas U. Marron
Y. Linda Wu
Anwaar Saeed
Brooke Wietharn
Lorenza Rimassa
Angelo Pirozzi
Antonella Cammarota
Tiziana Pressiani
Yi-Hsiang Huang
Samuel Phen
Amit G. Singal
Caterina Vivaldi
Gianluca Masi
Francesca Salani
Dominik Bettinger
Arndt Vogel
Martin Schoenlein
Johann von Felden
Kornelius Schulze
Henning Wege
Adel Samson
Peter R. Galle
Affiliated Authors:
Y. Linda Wu
Columbia Affiliation:
Author Keywords:
hepatocellular carcinoma
albi
bleeding risk
systemic treatment
elink
Publication Type:
Article
Unique ID:
10.2147/JHC.S462701
PMID:
40201222
DOI:
10.2147/JHC.S462701
Journal:
Journal of Hepatocellular Carcinoma
Publication Date:
Data Source:
Web of Science
Source Link:
View Web of Science Record

Record Created: